Phase I and DCE-MRI evaluation of NGR-TNF, a novel vascular targeting agent, in patients with solid tumors (EORTC 16041)
暂无分享,去创建一个
A. Heerschap | C. Punt | W. Fiedler | C. Bordignon | S. Marréaud | R. Belli | I. Desar | H. Laarhoven | S. V. Asten | C. V. Herpen